Advanced Filters
noise

Vac, Hungary Clinical Trials

A listing of Vac, Hungary clinical trials actively recruiting patients volunteers.

Found 3 clinical trials
S Sheng-Li Xue, M.D.

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Chidamide in combination with venetoclax and azacitidine (VAC) were expected to improve remission rate of patients following to VA regimen treatment failure.

18 - 80 years of age Both Phase 2
S Sheng-Li Xue, M.D.

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

This study is to investigate the therapeutic efficacy and side effect of venetoclax, azacytidine combined with chidamide for newly diagnosed acute monocytic leukemia patients that are ineligible for intensive chemotherapy

18 - 100 years of age Both Phase 2
M Markus M Heiss, Prof Dr

VAC-Stent Registry

This registry is intended to collect data on quality assurance and use of the VAC-Stent® and thus verify the suitability of the VAC-Stent® for sealing leakages in the oesophagus or colon. Furthermore, the safety and efficacy of the VAC-Stent® shall be proven.

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI